Here are five points:
1. The minimally invasive neurosurgery devices market is growing due to technological advancements and the rise in treatment of neurological disorders.
2. North America leads the market because of the area’s high volume of procedures. Europe follows second, fueled by its technological advances.
3. Asia Pacific, specifically India and China, will witness substantial growth.
4. Developing countries are not experiencing great growth in the market due to a lack of professionals and stringent reimbursement regulations.
5. Karl Storz GmbH & Co. KG, Olympus Corp., Conmed Corp., Richard Wolf GmbH, Boston Scientific, Integra LifeSciences, Aesculap Division, Smith & Nephew, Medtronic and NICO Corp. lead the market.
More articles on devices:
17 new device launches & releases — October 26, 2015
NuVasive shares drop 4.88%: 5 quick facts
Minority patients less likely to receive regional anesthesia during hip, knee replacement surgery — 5 findings
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
